News Headlines Article

Fears of Medicare for All, drug rebate overhaul feed selling of health insurer stocks
Modern Healthcare

Publicly traded health insurer stocks took a hit this week amid fears that Medicare for All momentum and the federal government’s proposal to nix drug rebates to pharmacy benefit managers could threaten their business models or even their existence.

The stock price of the largest publicly traded insurers were all trading down on Friday and for the week, with Anthem taking the biggest hit, falling almost 14%. Meanwhile, the S&P 500 stock index was up.